Stereotactic radiosurgery for glomus jugulare tumors

A preliminary report

Robert L. Foote, Robert J. Coffey, Deborah A. Gorman, John D. Earle, Paula J. Schomberg, Robert W. Kline, Steven E. Schild

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Purpose: This study was conducted to evaluate the toxicity and efficacy of stereotactic radiosurgery treatment of glomus jugulare tumors. Methods and Materials: Between March 1990 and January 1995, nine patients underwent stereotactic radiosurgery with the Leksell Gamma Knife Unit for glomus jugulare tumors. Previous treatment had failed in four patients. The seven female and two male patients had a median age of 67 years. Results: The median time from stereotactic radiosurgery to the most recent clinical follow-up was 20 months (range 7-65 months). Subjectively, 7 of 9 patients noted a decrease in the intensity of their symptoms. Objectively, 8 of 9 tumors remained stable in size by serial magnetic resonance imaging scans and one was smaller. There was no acute or chronic toxicity. Conclusion: This early experience suggests that stereotactic radiosurgery is a promising treatment far glomus jugulare tumors.

Original languageEnglish (US)
Pages (from-to)491-495
Number of pages5
JournalInternational Journal of Radiation Oncology Biology Physics
Volume38
Issue number3
DOIs
StatePublished - Jun 1 1997

Fingerprint

Glomus Jugulare Tumor
Radiosurgery
tumors
toxicity
magnetic resonance
Therapeutics
Magnetic Resonance Imaging
Neoplasms

Keywords

  • Chemodectomas
  • Glomus jugulare
  • Stereotactic radiosurgery

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Foote, R. L., Coffey, R. J., Gorman, D. A., Earle, J. D., Schomberg, P. J., Kline, R. W., & Schild, S. E. (1997). Stereotactic radiosurgery for glomus jugulare tumors: A preliminary report. International Journal of Radiation Oncology Biology Physics, 38(3), 491-495. https://doi.org/10.1016/S0360-3016(97)89482-5

Stereotactic radiosurgery for glomus jugulare tumors : A preliminary report. / Foote, Robert L.; Coffey, Robert J.; Gorman, Deborah A.; Earle, John D.; Schomberg, Paula J.; Kline, Robert W.; Schild, Steven E.

In: International Journal of Radiation Oncology Biology Physics, Vol. 38, No. 3, 01.06.1997, p. 491-495.

Research output: Contribution to journalArticle

Foote, RL, Coffey, RJ, Gorman, DA, Earle, JD, Schomberg, PJ, Kline, RW & Schild, SE 1997, 'Stereotactic radiosurgery for glomus jugulare tumors: A preliminary report', International Journal of Radiation Oncology Biology Physics, vol. 38, no. 3, pp. 491-495. https://doi.org/10.1016/S0360-3016(97)89482-5
Foote, Robert L. ; Coffey, Robert J. ; Gorman, Deborah A. ; Earle, John D. ; Schomberg, Paula J. ; Kline, Robert W. ; Schild, Steven E. / Stereotactic radiosurgery for glomus jugulare tumors : A preliminary report. In: International Journal of Radiation Oncology Biology Physics. 1997 ; Vol. 38, No. 3. pp. 491-495.
@article{b9b66f1123604bfa8669b4809768916e,
title = "Stereotactic radiosurgery for glomus jugulare tumors: A preliminary report",
abstract = "Purpose: This study was conducted to evaluate the toxicity and efficacy of stereotactic radiosurgery treatment of glomus jugulare tumors. Methods and Materials: Between March 1990 and January 1995, nine patients underwent stereotactic radiosurgery with the Leksell Gamma Knife Unit for glomus jugulare tumors. Previous treatment had failed in four patients. The seven female and two male patients had a median age of 67 years. Results: The median time from stereotactic radiosurgery to the most recent clinical follow-up was 20 months (range 7-65 months). Subjectively, 7 of 9 patients noted a decrease in the intensity of their symptoms. Objectively, 8 of 9 tumors remained stable in size by serial magnetic resonance imaging scans and one was smaller. There was no acute or chronic toxicity. Conclusion: This early experience suggests that stereotactic radiosurgery is a promising treatment far glomus jugulare tumors.",
keywords = "Chemodectomas, Glomus jugulare, Stereotactic radiosurgery",
author = "Foote, {Robert L.} and Coffey, {Robert J.} and Gorman, {Deborah A.} and Earle, {John D.} and Schomberg, {Paula J.} and Kline, {Robert W.} and Schild, {Steven E.}",
year = "1997",
month = "6",
day = "1",
doi = "10.1016/S0360-3016(97)89482-5",
language = "English (US)",
volume = "38",
pages = "491--495",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Stereotactic radiosurgery for glomus jugulare tumors

T2 - A preliminary report

AU - Foote, Robert L.

AU - Coffey, Robert J.

AU - Gorman, Deborah A.

AU - Earle, John D.

AU - Schomberg, Paula J.

AU - Kline, Robert W.

AU - Schild, Steven E.

PY - 1997/6/1

Y1 - 1997/6/1

N2 - Purpose: This study was conducted to evaluate the toxicity and efficacy of stereotactic radiosurgery treatment of glomus jugulare tumors. Methods and Materials: Between March 1990 and January 1995, nine patients underwent stereotactic radiosurgery with the Leksell Gamma Knife Unit for glomus jugulare tumors. Previous treatment had failed in four patients. The seven female and two male patients had a median age of 67 years. Results: The median time from stereotactic radiosurgery to the most recent clinical follow-up was 20 months (range 7-65 months). Subjectively, 7 of 9 patients noted a decrease in the intensity of their symptoms. Objectively, 8 of 9 tumors remained stable in size by serial magnetic resonance imaging scans and one was smaller. There was no acute or chronic toxicity. Conclusion: This early experience suggests that stereotactic radiosurgery is a promising treatment far glomus jugulare tumors.

AB - Purpose: This study was conducted to evaluate the toxicity and efficacy of stereotactic radiosurgery treatment of glomus jugulare tumors. Methods and Materials: Between March 1990 and January 1995, nine patients underwent stereotactic radiosurgery with the Leksell Gamma Knife Unit for glomus jugulare tumors. Previous treatment had failed in four patients. The seven female and two male patients had a median age of 67 years. Results: The median time from stereotactic radiosurgery to the most recent clinical follow-up was 20 months (range 7-65 months). Subjectively, 7 of 9 patients noted a decrease in the intensity of their symptoms. Objectively, 8 of 9 tumors remained stable in size by serial magnetic resonance imaging scans and one was smaller. There was no acute or chronic toxicity. Conclusion: This early experience suggests that stereotactic radiosurgery is a promising treatment far glomus jugulare tumors.

KW - Chemodectomas

KW - Glomus jugulare

KW - Stereotactic radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=0030741829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030741829&partnerID=8YFLogxK

U2 - 10.1016/S0360-3016(97)89482-5

DO - 10.1016/S0360-3016(97)89482-5

M3 - Article

VL - 38

SP - 491

EP - 495

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -